215 related articles for article (PubMed ID: 6154662)
1. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
Mantovani A; Allavena P; Sessa C; Bolis G; Mangioni C
Int J Cancer; 1980 May; 25(5):573-82. PubMed ID: 6154662
[TBL] [Abstract][Full Text] [Related]
2. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.
Allavena P; Introna M; Mangioni C; Mantovani A
J Natl Cancer Inst; 1981 Aug; 67(2):319-25. PubMed ID: 6943371
[TBL] [Abstract][Full Text] [Related]
4. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
[TBL] [Abstract][Full Text] [Related]
5. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
[TBL] [Abstract][Full Text] [Related]
6. Natural immunity against ovarian tumors.
Lotzová E; Savary CA; Freedman R; Bowen JM
Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):269-75. PubMed ID: 3491727
[TBL] [Abstract][Full Text] [Related]
7. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
8. Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ.
Introna M; Allavena P; Biondi A; Colombo N; Villa A; Mantovani A
J Natl Cancer Inst; 1983 Jan; 70(1):21-6. PubMed ID: 6337291
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of natural killer activity by human bronchoalveolar macrophages.
Bordignon C; Villa F; Allavena P; Introna M; Biondi A; Avallone R; Mantovani A
J Immunol; 1982 Aug; 129(2):587-91. PubMed ID: 6177770
[TBL] [Abstract][Full Text] [Related]
10. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
11. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
Uchida A; Moore M
Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
[TBL] [Abstract][Full Text] [Related]
12. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
13. Modulation of target cell susceptibility to human natural killer cells by interferon.
Moore M; White WJ; Potter MR
Int J Cancer; 1980 May; 25(5):565-72. PubMed ID: 6154661
[TBL] [Abstract][Full Text] [Related]
14. Human natural killing against ovarian carcinoma.
Shau H; Koren HS; Dawson JR
Br J Cancer; 1983 May; 47(5):687-95. PubMed ID: 6573908
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
16. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
17. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
18. Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin.
Peri G; Polentarutti N; Sessa C; Mangioni C; Mantovani A
Int J Cancer; 1981 Aug; 28(2):143-52. PubMed ID: 6172388
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells in human solid tumors.
Introna M; Mantovani A
Cancer Metastasis Rev; 1983; 2(4):337-50. PubMed ID: 6203638
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.
Timonen T; Ortaldo JR; Herberman RB
J Exp Med; 1981 Mar; 153(3):569-82. PubMed ID: 6166701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
